FDA Approves First AI Tool for Sepsis Prediction

The groundbreaking approval of Prenosis' Sepsis ImmunoScore marks a significant advancement in the integration of AI in healthcare diagnostics.

The FDA has approved Prenosis' AI-driven diagnostic tool, Sepsis ImmunoScore, marking the first AI tool to predict sepsis.
Sepsis ImmunoScore uses 22 parameters, including blood measures and vital signs, to assess a patient's risk of developing sepsis.
The tool is integrated into hospitals' electronic medical records, facilitating its use by healthcare professionals.
Prenosis plans to sell the Sepsis ImmunoScore across the U.S. and is expected to announce a distribution partnership soon.
The approval comes amid scrutiny of other AI diagnostic tools, highlighting the importance of accurate and reliable AI in healthcare.